SAT0464 MULTIPLE REBOUND-ASSOCIATED VERTEBRAL FRACTURES AFTER DENOSUMAB DISCONTINUATION IN RHEUMATOLOGY CLINIC
Sign Up to like & getrecommendations! Published in 2020 at "Annals of the Rheumatic Diseases"
DOI: 10.1136/annrheumdis-2020-eular.660
Abstract: Denosumab, a monoclonal antibody against RANKL, is an effective treatment for osteoporosis. Discontinuation of denosumab has been shown to lead in multiple vertebral fractures in some patients due to a severe acceleration of bone resorption… read more here.
Keywords: vertebral fractures; treatment; rebound associated; discontinuation ... See more keywords